Article
XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Aug 2004
Brewster Abenaa M, Alberg Anthony J, Strickland Paul T, Hoffman Sandy C, Helzlsouer Kathy
Abstract excerpt
BACKGROUND: Individuals with nonmelanoma skin cancer (NMSC) are at increased risk of developing subsequent cancers. Genetic predisposition to reduced DNA repair capacity may be an underlying susceptibility factor explaining the excess risk of malignancies. To test this hypothesis, a cohort study was conducted to examine the association between XPD Lys751Gln polymorphism and risk of a second primary cancer in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
